Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance
GastroenterologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Hepatobiliary & pancreatic diseases international : HBPD INT
- Publicado em
- 14 dez 2022
- Citações
- 8
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance
Xiao-Yin Jiang, Qi-Cong Zhu, Xiao-Jian Zhang, Ting Duan, Jiao Feng, Xin-Bing Sui, Xue-Ni Sun, Yi-Ping Mou
Descritores MeSH
- Pancreatic Neoplasms
- Carcinoma, Pancreatic Ductal
- RNA, Long Noncoding
- Cell Movement
- Cell Line, Tumor
- Cell Proliferation
- Gene Expression Regulation, Neoplastic
- Drug Resistance
- Humans
Veja também
Estudos relacionados
- LINC00657 exhibits oncogenic properties in prostate cancer and may serve as a prognostic biomarker in cancer
- Circular RNA AGFG1 motivates breast cancer cell proliferation, invasion, migration, and glycolysis by controlling microRNA-653-5p/14-3-3 protein epsilon
- High expression of AFAP1-AS1 is associated with poor prognosis of digestive system cancers: A meta-analysis
- STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer In Vivo